Clinical Trial Update: Attentional Mechanisms in SCD [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial at Vanderbilt investigating attentional mechanisms in Subjective Cognitive Decline, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Cognitive Decline

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Subjective Cognitive Decline | EARLY_Phase 1 | Status: RECRUITING